Clexane and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Revlimid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 944 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

On Jul, 19, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 32 people (0.22%) have Thrombophlebitis.

Among these 32 people:

How long have people been on Clexane when they have Thrombophlebitis? *

What is the gender of people who have Thrombophlebitis when taking Clexane? *

female: 59.26 %
male: 40.74 %

What is the age of people who have Thrombophlebitis when taking Clexane? *

What are other drugs people take besides Clexane? *

What are other side effects people have besides Thrombophlebitis? *

Rashes (redness): 9 people, 28.12%
Fever: 6 people, 18.75%
Diarrhea: 6 people, 18.75%
Itching: 5 people, 15.62%
Dehydration (dryness resulting from the removal of water): 5 people, 15.62%
High Blood Pressure: 5 people, 15.62%
Joint Pain: 5 people, 15.62%
Weakness: 5 people, 15.62%
Hyperkalemia (damage to or disease of the kidney): 4 people, 12.50%
Neuropathy Peripheral (surface nerve damage): 4 people, 12.50%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 8 people, 25.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 12.50%
Colon Cancer: 3 people, 9.38%
High Blood Pressure: 3 people, 9.38%
Nephropathy Toxic (damage to kidney due to toxins): 2 people, 6.25%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 6.25%
Thrombocytopenia (decrease of platelets in blood): 2 people, 6.25%
Device Related Infection: 2 people, 6.25%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 6.25%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (944 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.